Identification of Chemical Composition of Sanguisorba officinalis L. and Its Major Metabolites in Rats by UHPLC-Q-TOF/MS
-
摘要: 目的 采用超高效液相色谱和-四级杆串联飞行时间质谱(UHPLC-Q-TOF/MS)法分析地榆水提物在大鼠血清、尿液及粪便中的原型成分及代谢产物, 探讨地榆中活性成分在大鼠体内的代谢途径。方法 采用Thermo AcclaimTM RSLC 120 C18色谱柱(3.0 mm×100 mm, 2.2 μm), 以0.1%甲酸水溶液(A)-乙腈(B)为流动相进行梯度洗脱, 流速0.4 mL·min-1, 进样量3 μL, 柱温40 ℃。运用电喷雾离子源(ESI), 扫描范围m/z 50~1 500, 正、负离子模式采集数据。通过比较灌胃地榆水提物后大鼠血清、尿液和粪便样品和空白组样品的差异, 对原型成分及其代谢产物进行鉴定。结果 灌胃给予地榆水提物后, 从大鼠血清、尿液及粪便中鉴定出69个外源性成分, 包括24个原型成分和45个代谢产物。其中24个原型成分包括16个酚类成分、7个三萜类成分及1个单萜烯醇苷。地榆水提物在大鼠体内的代谢途径主要包括还原、甲基化、脱水、氧化、硫酸化及葡萄糖醛酸结合等。结论 所鉴定出的原型成分和代谢产物可为进一步解析地榆体内代谢过程, 阐明其药效物质基础提供实验依据。
-
关键词:
- 地榆 /
- UHPLC-Q-TOF/MS /
- 原型成分 /
- 代谢产物
Abstract: OBJECTIVE To analyze the prototype components and metabolites of aqueous extract of Sanguisorba officinalis L. by UHPLC-Q-TOF/MS in feces, urine and plasma of rats and explore its metabolic pathways.METHODS Chromatographic separation was performed on the Thermo AcclaimTM RSLC 120 C18 column (3.0 mm×100 mm, 2.2 μm). The mobile phase was consisted of 0.1% formic acid in water (solvent A) and acetonitrile (solvent B). The sample injection volume was 3 μL and the flow rate was set to 0.4 mL·min-1. The column temperature was maintained at 40 ℃. The detection was carried out over a mass range of m/z 50-1 500 and equipped with an electrospray ionization (ESI) source operating in positive mode and negative mode. Chemical composition on Sanguisorba officinalis L. and its major metabolites were identified by comparing the differences in feces, urine and plasma between adminstration samples and blank samples in rats.RESULTS After intragastric administration of the aqueous extract of Sanguisorba officinalis L., 69 exogenous components were identified from rat plasma, urine and feces, including 24 prototype components and 45 metabolites. 24 prototype components included 16 phenolics, 7 triterpenes, and a monoterpene glycoside. The metabolic pathways of the aqueous extract of Sanguisorba officinalis L. in rats mainly included reduction, methylation, dehydration, oxidation, sulfation, and glucuronidation.CONCLUSION The identified prototype drugs and the metabolites can supply a clear material basis for the further study of efficacy of Sanguisorba officinalis L..-
Key words:
- Sanguisorba officinalis L. /
- UHPLC-Q-TOF/MS /
- prototypes /
- metabolites
-
表 1 地榆水提物化学成分鉴定
峰号 tR/min 化合物 分子式 m/z[M-H/+HCOO]- 碎片离子 m/z[M+H]+ 碎片离子 理论值 实测值 δ 理论值 实测值 δ C1 1.43 没食子酸糖苷
(Gallic acid glycoside)C13H16O10 331.067 1 331.067 0 -0.3 271.045 1, 211.023 9,
169.013 2,125.023
8333.081 6 333.081 4 -0.7 C2 1.85 没食子酸*(Gallic acid) C7H6O5 169.014 3 169.015 0 4.5 125.023 3 171.028 8 171.028 7 -0.8 C3 3.7 没食子儿茶素(Gallocatechin) C15H14O7 305.066 7 305.067 0 1.0 219.064 5,179.033 7,
137.023 5,125.023
8307.081 2 307.081 5 0.7 C4 3.73 表没食子儿茶素
(Epigallocatechin)C15H14O7 305.066 7 305.067 0 1.0 247.023 4 307.081 2 307.081 5 0.7 C5 5.34 没食子酰基-甲基葡萄糖苷
(Methyl-6-O-galloyl-β-D-
glucopyranoside)C14H18O10 345.082 7 345.082 8 0.2 313.054 1,169.013 2 347.097 3 347.097 4 0.4 315.071 1,
171.028 5C6 5.57 表儿茶素-(4→8)-没食
子儿茶素(Epicatechin-
(4→8)-gallocatechin)C30H26O13 593.130 1 593.129 5 -0.9 441.081 8,423.072 6,
305.066
9,283.025 2,
255.029 9595.144 6 595.144 0 -1.1 455.350 1,
437.338 8C7 6.71 Sanguiin H4 C27H22O18 633.073 3 633.072 8 -0.9 300.997 6 635.087 9 635.087 3 -0.9 C8 7.32 原花青素B3
(Procyanidin B3)C30H26O12 577.135 2 577.134 8 -0.7 425.086 8,407.076 2 579.149 7 579.148 8 -1.6 427.102 3,
409.091 9C9 7.48 6-O-Galloylnorbergerin C20H18O13 467.082 0 467.081 7 -0.7 315.066 1 C10 7.53 二没食子酰葡萄糖苷
(Bisgalloyl glucoside)C20H20O14 483.078 0 483.077 3 -1.5 331.064 0,313.055 1,
271.044
6,211.023 4,
193.006 9,169.012
5485.092 6 485.092 9 0.6 C11 7.63 原花青素C2(Procyanidin C2) C45H38O18 865.198 5 865.198 8 0.3 695.143 7,577.137 0,
407.075 2867.213 1 867.212 1 -1.1 C12 7.86 儿茶素*(Catechin) C15H14O6 289.071 8 289.071 9 0.4 441.082 9,245.079 9,
203.070 2291.086 3 291.086 3 0 165.054 3,
147.044
2, 139.039 0,
123.044 6C13 7.89 表儿茶素(Epicatechin) C15H14O6 289.071 8 289.071 9 0.4 245.080 6,203.070 3,
161.059 6291.086 3 291.086 3 0 C14 8.66 三没食子酰葡萄糖苷
(Trigalloyl glucoside)C27H24O18 635.089 0 635.088 2 -1.3 483.076 3,465.066 3,
313.053 9,221.020
2637.103 5 637.102 3 -1.9 C15 8.95 短叶苏木酚酸
(Brevifolincarboxylic acid)C13H8O8 291.014 6 291.014 8 0.6 247.060 0,203.070 3 293.029 2 293.029 3 0.3 273.073 3 C16 9.09 二没食子酰基-D-甲基吡喃
葡萄糖苷(Methyl 4,6-di-O-
galloyl-β-D-glucopyranoside)C21H22O14 497.093 7 497.092 8 -1.8 497.093 5,345.082 3 499.108 2 499.107 8 -1 C17 9.31 2, 6-乙酰氧基-5, 7-二羟
基-8-甲氧基色原酮(2,6-
Acetoxy-5,7-dihydroxy-8-
methoxychromone)C14H12O9 323.040 9 323.040 6 -0.8 325.055 4 325.055 2 -0.6 293.029 2 C18 9.32 没食子酰鞣花酸
(Galloyl ellagic acid)C21H10O13 469.004 9 469.004 9 0 316.994 0,300.998 7 471.019 4 471.019 1 -0.8 C19 9.35 地榆酸双内酯
(Dilin dilactone)C21H10O13 469.004 9 469.004 9 0 314.978 3,300.998 7,
286.983 7,230.992
4471.019 4 471.019 1 -0.8 C20 9.72 甲氧基没食子酸甲酯-5-O-硫酸酯(Methyl methoxygallate-5-O-sulfate) C9H10SO8 277.002 4 277.002 4 0 197.043 9,182.020 2,
166.996
7,139.002 7,
123.007 4279.016 9 279.016 7 -0.9 199.059 7 C21 10 3-O-没食子酰基-原花青素B3(3-O-Galloylprocyanidin B3) C37H30O16 729.146 1 729.146 1 -0.1 577.136 1,407.076 8 731.160 7 731.159 1 -2.1 C22 10.47 非瑟酮醇-(4β-8)-儿茶素(Fisetinol-(4β-8)-catechin) C30H26O11 561.140 2 561.139 5 -1.3 409.092 7,391.081 7,
289.070
7,245.080 5,
203.069 1563.154 8 563.153 8 -1.8 C23 10.69 鞣花酸-4-吡喃阿拉伯糖苷(Ellagic acid-4-arabinopyranoside) C19H14O12 433.041 3 433.040 5 -1.8 435.055 8 435.056 1 0.6 303.013 1 C24 11.02 2, 3, 4, 6-O-四没食子酰基-β-D-葡萄糖苷(2,3,4,6-O-Tetragalloyl-β-D-glucoside) C34H28O22 787.100 0 787.100 0 0.1 635.089 3,617.077 1,
465.065
9,447.056 6,
313.055 1,295.045
1789.114 5 789.113 5 -1.3 C25 11.31 鞣花酸*(Ellagic acid) C14H6O8 300.999 0 300.998 8 -0.7 300.996 3,283.995 6,
229.012 6303.013 5 303.013 3 -0.9 C26 11.58 三没食子酰基-β-D-甲
基葡萄糖苷(Trigalloyl-
β-D-Methyl glucoside)C28H26O18 649.104 6 649.104 1 -0.8 497.094 6,479.085 1,
345.082 1,327.070
6651.119 2 651.118 2 -1.5 C27 11.63 儿茶素没食子酸酯
(Catechin gallate)C22H18O10 441.082 7 441.081 7 -2.4 441.082 9,289.071 0,
245.079 9,203.070
2443.097 3 443.096 6 -1.5 C28 11.69 金丝桃苷(Hyperoside) C21H20O12 463.088 2 463.087 5 -1.6 463.088 7,301.034 6 465.102 8 465.102 2 -1.2 C29 11.9 五没食子酰葡萄糖苷
(Pentagalloyl glucoside)C41H32O26 939.110 9 939.110 6 -0.3 769.093 4,
617.081 0,
169.013 2C30 12.63 2-甲基-3-乙酰氧基-苯并呋喃-5, 6-O-硫酸酯(2-Methyl-3-acetoxy-benzofuran-5,6-O-sulfate) C12H12O11S2 394.974 8 394.970 5 -11 315.013 1,299.989 4 396.989 4 396.985 6 -9.5 C31 15.54 3, 4'-O-二甲基鞣花酸-4-O-β-D-木糖苷(3, 4'-O-Dimethylellagic acid-4-O-β-D-xyloside) C21H18O12 461.072 6 461.071 5 -2.3 329.029 5,314.006 3,
298.982 0,285.003
0463.087 1 463.086 2 -2.1 C32 15.61 3, 4'-O-二甲基鞣花酸(3,4'-O-Dimethyl ellagic acid) C16H10O8 329.030 3 329.029 6 -2.1 314.004 0,298.980 2,
285.001 5,258.015
0331.044 8 331.044 6 -0.8 C33 15.63 3, 4'-O-二甲基鞣花酸-4-O-硫酸酯(3,4'-O-Dimethylellagic acid-4-O-sulfate) C16H10O11S 408.987 1 408.985 8 -3.1 329.027 6,314.004 3,
298.980 0411.001 7 411.001 3 -1.0 331.044 7,
316.020 3,
300.999 9C34 15.98 槲皮素*(Quercetin) C15H10O7 301.035 4 301.034 5 -3.0 301.030 9,273.037 7,
178.996
5,151.002 1,
121.029 2303.049 9 303.049 7 -0.8 C35 16.47 香叶醇-1-O-呋喃阿拉伯糖基-(1→6)-β-D-吡喃葡萄糖苷(Geranyl-1-O-furanyl-arabinose-(1→6)-β-D-glucopyranoside) C21H36O10 447.223 6 447.222 1 -3.3 447.216 9,315.178 0,
251.075
3,221.061 3,
191.055 2,179.053
5449.238 1 449.237 4 -1.6 C36 16.48 3, 3', 4'-O-三甲基鞣花酸-4-O-D-木糖苷(3,3',4'-O-Trimethylellagic acid-4-O-D-xyloside) C22H20O12 475.088 2 475.086 8 -2.9 343.053 9,328.026 7,
313.001 4477.102 8 477.102 5 -0.6 C37 16.83 3, 3', 4'-O-三甲基鞣花酸-4-O-硫酸酯(3,3',4'-O-Trimethylellagic acid-4-O-sulfate) C17H12O11S 423.002 8 423.001 5 -3.0 343.042 8,328.019 5,
312.996 3425.017 3 425.016 9 -1.0 C38 18.1 山柰酚*(Kaempferol) C15H10O6 285.040 5 285.039 7 -2.7 285.038 5,239.037 0,
185.061 7,93.035
4287.055 0 287.054 6 -1.4 C39 19.11 地榆皂苷Ⅰ*
(ZiyuglycosideⅠ)C41H66O13 811.447 5 811.449 9 3.0 765.444 5,603.389 0,
585.380 2C40 19.14 3-氧代-12-烯-28-乌苏酸(3-Oxo-12-ene-28-ursic acid) C30H46O3 453.337 4 453.335 3 -4.6 455.352 0 455.350 9 -2.5 437.340 8,
409.345 2,
391.335 5C41 19.96 3, 3', 4'-O-三甲基鞣花酸(3,3',4'-O-Trimethylellagic acid) C17H12O8 343.045 9 343.045 2 -2.2 328.020 2,312.996 6 345.060 5 345.059 8 -1.9 C42 22.22 坡模醇酸(Pomolic acid) C30H48O4 471.348 0 471.345 7 -4.8 473.362 5 473.360 9 -3.4 455.350 1,
437.338 8C43 22.23 地榆皂苷Ⅲ
(Ziyuglycoside Ⅲ)C36H58O9 679.405 2 679.404 6 -1.3 633.399 2, 471.355 1,
453.335 0C44 23.11 地榆皂苷Ⅱ*
(Ziyuglycoside Ⅱ)C35H56O8 603.389 5 603.390 8 2.2 585.379 8 605.404 8 605.403 0 -3.0 C45 23.72 3, 11-二酮-19α-羟基-乌苏-12-烯-28-酸(3,11-Dioxo-19α-hydroxy-urs-12-en-28-oic acid) C30H44O5 483.311 6 483.310 3 -2.7 421.310 7 485.326 2 485.324 5 -3.5 439.318 4 注: *表示化合物与对照品确认。 表 2 血浆、尿液和粪便中原型成分和代谢产物的鉴定
峰号 tR/min 鉴定结果 离子模式 分子式 理论值 实测值 δ 碎片离子 来源 C2 1.84 没食子酸, 原型(Gallic acid,parent) [M-H]- C7H6O5 169.014 3 169.015 0 4.5 169.012 6,125.025 1 粪便 C2-1 9.48 1,3-二甲氧基没食子酸(1,3-Dimethoxygallic acid) [M-H]- C9H10O5 197.045 6 197.046 3 3.6 123.008 3 粪便 C2-2 7.88 3-甲氧基没食子酸(3-Methoxygallic acid) [M-H]- C8H8O5 183.029 9 183.030 2 1.5 123.077 7 粪便 C2-3 1.84 焦没食子酸(Pyrogallic acid) [M-H]- C6H6O3 125.024 4 125.025 4 8.1 081.035 8 粪便 C2-4 7.87 C2失去2个氧原子(Two oxygen atoms loss of C2) [M-H]- C7H6O3 137.024 4 137.025 3 6.8 93.034 5,65.006 0 粪便 C2-5 9.67 C2甲基化和葡萄糖醛酸化(Methylation and glucuronidation of C2) [M-H]- C15H18O11 373.077 6 373.077 4 -0.7 197.044 9 粪便,
血浆C2-6 10.21 C2甲基化和硫酸化(Methylation and sulfated of C2) [M-H]- C9H10O8S 277.002 4 277.002 5 0.6 166.997 7 粪便,
血浆C2-7 15.15 C2结合甘氨酸(Glycine conjugated of C2) [M-H]- C9H9NO6 226.035 7 226.028 0 -34 182.043 6 粪便,
血浆C3 13.33 儿茶素, 原型(Gallocatechin,parent) [M-H]- C15H14O7 305.066 7 305.063 8 -9.4 305.065 3,125.036 5 粪便 C3-1 14.86 C3甲基化(Methylation of C3) [M-H]- C16H16O7 319.089 8 319.082 5 0.6 213.068 9,187.055 5 粪便,
尿液C3-2 7.01 C3氧化(Oxidation of C3) [M-H]- C15H14O8 321.067 1 321.058 6 -9.5 215.071 3,191.070 9,
147.081 5粪便 C4-1 12.31 C4甲基化(Methylation of C4) [M-H]- C16H16O7 319.089 8 319.082 5 0.6 191.070 9,131.049 5 粪便,
尿液C4-2 6.03 C4氧化(Oxidation of C4) [M-H]- C15H14O8 321.067 1 321.059 8 -5.6 303.149 6,197.047 0,
119.052 0粪便 C7 14.73 Sanguiin H4, 原型(Sanguiin H4,parent) [M-H]- C27H22O18 633.073 3 633.067 3 -9.6 465.068 2 粪便 C8 7.37 原花青素B3, 原型(Procyanidin B3,parent) [M-H]- C30H26O12 577.135 2 577.134 5 -1.2 577.135 7,451.100 4,
425.088
8,407.076 4,
289.071 7,245.082
3粪便 C8-1 11.71 C8甲基化(Methylation of C8) [M-H]- C31H28O12 591.158 9 591.151 6 1.4 381.061 5,230.020 4 粪便 C8-2 6.99 C8氧化(Oxidation of C8) [M-H]- C30H26O13 593.136 6 593.129 3 -1.3 454.135 6,397.094 0,
137.022 1粪便 C11 7.64 原花青素C2, 原型(Procyanidin C2,parent) [M-H]- C45H38O18 865.198 5 865.198 2 -0.3 695.095 0,577.132 3,
451.097 4,407.081
4粪便 C11-1 3.67 C11氧化(Oxidation of C11) [M-H]- C45H38O19 881.201 9 881.194 6 1.3 881.188 9 粪便 C12 8.78 儿茶素, 原型(Catechin,parent) [M-H]- C15H14O6 289.071 8 289.072 0 0.9 289.181 2,137.024 0 粪便 C12-1 11.64 C12甲基化(Methylation of C12) [M-H]- C16H16O6 303.094 5 303.087 7 1 191.069 8,153.019 5 粪便 C12-2 11.01 C12氧化(Oxidation of C12) [M-H]- C15H14O7 305.074 6 305.066 1 -8.5 223.098 8,165.065 2,
125.019 7粪便 C13 8.76 表儿茶素, 原型(Epicatechin,parent) [M-H]- C15H14O6 289.071 8 289.072 0 0.9 289.072 5,245.046 7,
203.069 7粪便 C13-1 16.54 C13甲基化(Methylation of C13) [M-H]- C16H16O6 303.094 5 303.087 3 -0.5 285.077 3,191.069 8,
153.019 5,69.001
0粪便 C13-2 3.75 C13氧化(Oxidation of C13) [M-H]- C15H14O7 305.074 6 305.067 4 2.2 167.038 6,139.037 8 粪便 C15 8.37 短叶叶酸, 原型(Brevifolincarboxylic acid,parent) [M-H]- C13H8O8 291.014 6 291.014 8 0.5 247.023 5,219.028 0,
191.033 4粪便 C17 10.73 2,6-乙酰氧基-5,7-二羟基-8-甲氧基色酮, 原型(2,6-Acetoxy-5,7-dihydroxy-8-methoxychromone,parent) [M-H]- C14H12O9 323.040 9 323.040 7 -0.4 232.040 9,219.028 4 粪便 C20 10.21 甲氧基没食子酸甲酯-5-O-硫酸盐, 原型(Methyl methoxygallate-5-O-sulfate,parent) [M-H]- C9H10SO8 277.002 4 277.002 5 0.6 197.045 2,182.021 9,
166.997 7粪便,
血浆C21 10 3-O-没食子酰原花青素B3, 原型(3-O-Galloyl-procyanidin B3,parent) [M-H]- C37H30O16 729.146 1 729.146 2 0.1 729.150 3,577.137 8,
559.120
7,425.089 0,
407.077
7,289.071 6,
269.045 1粪便 C22 10.48 非瑟酮醇-(4β-8)-儿茶素,原型(Fisetinol-(4β-8)-catechin,parent) [M-H]- C30H26O11 561.140 2 561.139 7 -0.9 561.139 8,289.071 4 粪便 C25-1 15.17 尿石素A(Urolithin A) [M-H]- C13H8O4 227.035 0 227.035 5 2.5 227.032 2,198.030 5 粪便 C25-2 12.31 C25-1甲基化和硫酸化(Methylation and sulfated of C25-1) [M-H]- C13H8O7S 306.991 8 306.991 7 -0.3 227.034 5,198.032 2,
183.045 2粪便,
血浆,
尿液C25-3 20.31 C25-1甲基化(Methylation of C25-1) [M-H]- C14H10O4 241.050 6 241.052 0 5.5 198.027 0, 154.042 9 血浆 C25-4 13.12 C25-1葡萄糖醛酸化(Glucuronidation of C25-1) [M-H]- C19H16O10 403.067 1 403.067 0 -0.3 227.119 5 粪便,
血浆,
尿液C25-5 12.76 尿石素C(Urolithin C) [M-H]- C13H8O5 243.029 9 243.030 4 2.2 215.033 7 粪便 C25-6 13.15 C25-5氧化(Oxidation of C25-5) [M-H]- C13H6O5 241.014 3 241.014 6 1.5 213.019 2,198.033 2,
185.024
5,169.027 9,
157.028 9,129.034
5粪便 C25-7 12.09 尿石素D(Urolithin D) [M-H]- C13H8O6 259.024 8 259.025 6 3.2 241.013 5, 213.018 4 粪便,
尿液C25-8 10.25 C25-7还原(Reduction of C25-7) [M-H]- C13H10O6 261.040 5 261.040 7 1 246.017 2,217.013 8,
189.019 1粪便,
尿液C25-9 10.12 尿石素M5(Urolithin M5) [M-H]- C13H8O7 275.019 7 275.020 1 1.4 257.009 2,229.014 0,
203.034
1,173.024 5,
145.029 5粪便,
尿液C25-10 13.78 C25甲基化(Methylation of C25) [M-H]- C15H8O8 315.021 8 315.014 5 -0.3 300.994 4, 245.002 7 粪便,
血浆C27 12.65 儿茶素没食子酸, 原型(Catechin gallate,parent) [M-H]- C22H18O10 441.082 7 441.082 0 -1.6 289.187 1 粪便 C27-1 11.82 C27还原(Hydrogenation of C27) [M-H]- C22H20O10 443.104 4 443.097 1 -2.9 381.141 9,275.091 3,
123.009 8粪便,
血浆C27-2 9.77 C27甲基化(Methylation of C27) [M-H]- C23H20O10 455.108 2 455.101 0 5.7 373.207 5,178.027 5,
80.996 1粪便,
尿液C27-3 2.56 C27氧化(Oxidation of C27) [M-H]- C22H18O11 457.086 0 457.078 8 2.4 287.032 8,275.054 5,
257.047 2粪便,
血浆C28-1 12.17 C28甲基化(Methylation of C28) [M-H]- C22H22O12 477.111 0 477.103 7 -0.2 395.151 3,269.045 9 粪便,
尿液C28-2 6.37 C28还原(Hydrogenation of C28) [M-H]- C21H22O12 465.110 3 465.103 0 -1.9 357.066 2,289.068 7,
151.040 5粪便 C31 15.54 3, 4'-O-二甲基鞣花酸-4-O-β-D木糖苷, 原型(3, 4'-O-Dimethylellagic acid-4-O-β-D-xyloside,parent) [M-H]- C21H18O12 461.072 6 461.070 6 -4.2 329.032 6 粪便,
血浆C33 16.01 3, 4'-O-二甲基鞣花酸-4-O-硫酸酯, 原型(3,4'-O-Dimethylellagic acid-4-O-sulfate,parent) [M-H]- C16H10O11S 408.987 1 408.986 2 -2.2 329.032 6,314.006 7,
298.984 7粪便,
血浆C34-1 10.53 C34甲基化(Methylation of C34) [M-H]- C16H12O7 315.060 9 315.051 4 1.3 315.045 0,271.168 7,
183.105 3粪便,
尿液C34-2 16.91 C34还原(Hydrogenation of C34) [M-H]- C15H12O7 303.061 1 303.053 8 9.1 223.096 1,123.081 2 血浆 C34-3 8.76 C34氧化(Oxidation of C34) [M-H]- C15H10O8 317.039 1 317.031 8 4.8 237.075 8,172.075 1,
80.965 1血浆 C35 16.44 Geranyl-1-O-furanyl-arabinose(1→6)-β-D-glucopyranoside, 原型 [M-H]- C21H36O10 471.219 6 471.220 1 1.1 471.217 2,335.091 3 血浆 C37 17.03 3, 3', 4'-O-三甲基鞣花酸-4-O-硫酸酯, 原型(3,3',4'-O-Trimethylellagic acid-4-O-sulfate,parent) [M-H]- C17H12O11S 423.002 8 423.001 4 -3.2 343.044 7,328.021 5,
312.997 9粪便,
血浆C38-1 21.75 C38甲基化(Methylation of C38) [M-H]- C16H12O6 299.063 3 299.056 0 -0.5 256.035 6,183.044 1,
159.043 6粪便 C38-2 13.95 C38还原(Hydrogenation of C38) [M-H]- C15H12O6 287.065 8 287.058 5 8.3 207.101 6,149.058 1,
80.966 3血浆 C38-3 9.33 C38氧化(Oxidation of C38) [M-H]- C15H10O7 301.045 4 301.038 2 9.3 177.091 5,123.007 9,
79.958 8血浆 C39 19.14 地榆皂苷Ⅰ, 原型(ZiyuglycosideⅠ, parent) [M-H]- C41H66O13 765.442 3 765.444 2 2.4 603.389 2 粪便,
血浆C39-1 23.13 C39-Glu [M-H]- C35H56O8 603.390 2 603.388 2 -3.4 585.380 7 粪便 C39-2 24.46 C39-Glu-Ara [M-H]- C30H48O4 471.348 0 471.346 3 -3.6 453.335 6 粪便 C39-3 22.25 C39-Ara [M+Cl]- C36H58O9 669.376 4 669.375 8 -0.8 471.347 7,453.339 1 粪便 C39-4 24.88 C39-Glu-Ara-2H [M-H]- C30H46O4 469.332 3 469.330 2 -4.6 451.320 8,407.330 7 粪便 C39-5 22.4 C39-Glu-Ara-O [M-H]- C30H48O3 455.353 1 455.348 9 -9.1 437.336 0 尿液 C40 24.44 3-氧代-12-烯-28-乌苏酸, 原型(3-oxo-12-ene-28-ursic acid,parent) [M+H]+ C30H46O3 455.352 0 455.350 2 -3.8 437.348 9,409.329 3,
391.286 4粪便,
血浆C41 19.99 3, 3', 4'-O-三甲基鞣花酸, 原型(3,3',4'-O-Trimethylellagic acid, parent) [M-H]- C17H12O8 343.045 9 343.045 5 -1.3 328.020 7,312.997 0 粪便,
血浆C42 24.45 坡模醇酸, 原型(Pomolic acid,parent) [M+H]+ C30H48O4 473.362 5 473.360 6 -4 455.351 8,437.347 1 粪便,
血浆C42-1 21.94 C42氧化(Oxidation of C42) [M+H]+ C30H48O5 489.348 1 489.355 4 -4.2 453.333 6,281.171 0,
191.177 6,159.116
5粪便 C43 22.25 地榆皂苷Ⅲ, 原型(Ziyuglycoside Ⅲ,parent) [M-H]- C36H58O9 633.400 1 633.402 7 4.1 471.346 4 粪便 C44 23.13 地榆皂苷Ⅱ, 原型(Ziyuglycoside Ⅱ,parent) [M-H]- C35H56O8 603.389 5 603.391 5 -3.3 585.380 3 粪便,
尿液C45 21.76 3, 11-二酮-19α-羟基-乌苏-12-烯-28-酸, 原型(3,11-Dioxo-19α-hydroxy-urs-12-en-28-oic acid, parent) [M+H]+ C30H44O5 485.326 2 485.325 3 -1.8 439.321 5 粪便 -
[1] 国家药典委员会. 中华人民共和国药典: 一部[M]. 北京: 中国医药科技出版社, 2020: 130-131. [2] SU XD, GUO RH, YANG SY, et al. Anti-bacterial effects of components from Sanguisorba officinalis L. on vibrio vulnificus and their soluble epoxide hydrolase inhibitory activity[J]. Nat Prod Res, 2019, 33(23): 3445-3449. doi: 10.1080/14786419.2018.1478825 [3] WU CC, YAO MC, LI W, et al. Simultaneous determination and pharmacokinetics study of six triterpenes in rat plasma by UHPLC-MS/MS after oral administration of Sanguisorba officinalis L. extract[J]. Molecules, 2018, 23(11): 2980. doi: 10.3390/molecules23112980 [4] SU XD, GUO RH, LI HX, et al. Anti-allergic inflammatory components from Sanguisorba officinalis L[J]. Bioorg Med Chem Lett, 2018, 28(12): 2210-2216. doi: 10.1016/j.bmcl.2018.04.033 [5] 许维桐, 霍志鹏, 雷磊, 等. HPLC-IT-TOF/MS分析地榆水煎液的化学成分群[J]. 中草药, 2018, 49(6): 1277-1288. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201806008.htm [6] LACHOWICZ S, OSZMIA AN' SKI J, RAPAK A, et al. Profile and content of phenolic compounds in leaves, flowers, roots, and stalks of Sanguisorba officinalis L. determined with the LC-DAD-ESI-QTOF-MS/MS analysis and their in vitro antioxidant, antidiabetic, antiproliferative potency[J]. Pharmaceuticals, 2020, 13(8): 191. doi: 10.3390/ph13080191 [7] 王森业, 殷博迪, 王玉宁, 等. 不同方法提取地榆总三萜含量的比较及其抗氧化活性研究[J]. 食品研究与开发, 2019, 40(6): 111-115. doi: 10.3969/j.issn.1005-6521.2019.06.020 [8] ZHU HL, CHEN G, CHEN SN, et al. Characterization of polyphenolic constituents from Sanguisorba officinalis L. and its antibacterial activity[J]. Eur Food Res Technol, 2019, 245(7): 1487-1498. doi: 10.1007/s00217-019-03276-2 [9] 黄楷迪, 朱西杰, 牛阳, 等. 复方蜥蜴散大鼠血浆、尿液、胆汁、粪便中代谢产物的鉴定[J/OL]. 中草药, 1-10. https://kns.cnki.net/kcms/detail/12.1108.R.20210527.0856.004.html. [10] ZHU C, CAI T, JIN Y, et al. Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes[J]. Pharmacol Res, 2020, 159: 104935. doi: 10.1016/j.phrs.2020.104935 [11] 康立欣, 许振鹏, 刘艳, 等. 关黄柏水提物在大鼠血清、尿液和粪便中原型成分及其代谢产物的UPLC-Orbitrap Fusion Lumos Tribrid-MS鉴定[J]. 中国实验方剂学杂志, 2021, 27(11): 139-146. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202111021.htm [12] 吕苗凯, 霍志鹏, 刘元雪, 等. 地榆成分在D101型大孔树脂和聚酰胺树脂上保留行为的LCMS-IT-TOF分析[J]. 中国实验方剂学杂志, 2020, 26(14): 152-163. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202014023.htm [13] WANG GJ, FU HX, YE W, et al. Comprehensive characterization of the in vitro and in vivo metabolites of ziyuglycoside Ⅰ in rat microsome, intestinal flora, excretion specimen and fresh tissues based on LC-Q-TOF/MS[J]. J Pharm Biomed Anal, 2016, 128: 191-200. doi: 10.1016/j.jpba.2016.05.032 [14] 周本宏, 汪静, 吴玥, 等. 地榆鞣质在大鼠尿液中代谢产物分析[J]. 中国现代中药, 2017, 19(6): 784-793. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX201706012.htm [15] 罗艳, 王寒, 原忠. 地榆中三萜皂苷类成分及其抗炎活性研究[J]. 中国药物化学杂志, 2008, 18(2): 138-141. doi: 10.3969/j.issn.1005-0108.2008.02.015 [16] WANG L, LI S, LI J, et al. Comprehensive metabolic profiling of Alismatis rhizoma triterpenes in rats based on characteristic ions and a triterpene database[J]. J Pharm Anal, 2021, 11(1): 96-107. doi: 10.1016/j.jpha.2020.03.010 [17] 肖玉欣, 王楠, 王婧, 等. 鞣花酸和尿石素类代谢产物的生物活性及其对肠道健康的积极作用[J/OL]. 食品科学, 1-14. https://kns.cnki.net/kcms/detail/11.2206.TS.20210602.1339.002.html. [18] 尹培培, 闫林林, 曹若愚, 等. 鞣花酸代谢产物: 尿石素的研究进展[J]. 食品科学, 2015, 36(7): 256-260. https://www.cnki.com.cn/Article/CJFDTOTAL-SPKX201507047.htm